Trump Proposes Tariffs on Imported Generic Medicines, Raising Concerns Over Production and Pricing
President Trump's proposed tariffs on imported generic medicines could significantly impact the pharmaceutical industry, particularly affecting low-cost drug manufacturers' ability to compete and maintain pricing structures. The tariffs, which could reach as high as 200%, raise concerns about the future of generic drug production and pricing in the U.S.